Independent fund research. Built on SEC filings.

How we research funds

ETF · Large Blend · Fidelity

FMED Performance & Returns History

Ticker FMED · · Holdings as of May 31, 2026

Expense ratio
0.5%$50/yr per $10k
5-yr return
−0.2%annualized
1-yr return
+9.7%as of Sep 2026
Net assets
$41.0Mall share classes
Holdings
70

Bottom line

How has FMED performed?

As of Sep 30, 2026, FMED returned +9.7% over the past year, −0.2% a year over five years. That means $10,000 invested five years earlier would have grown to about $9,900. Its five-year return beat 2% of large blend funds we track. Its best quarter was +9.6% and its worst −16.2%.

Updated Sep 30, 2026

FMED annual returns by year

FMED calendar-year returns 2021: +11.0%; 2022: −21.7%; 2023: +1.4%; 2024: +2.5%; 2025: +9.7% +11.0% 2021 −21.7% 2022 +1.4% 2023 +2.5% 2024 +9.7% 2025
Fund gain (+) Fund loss (−)
Year20252024202320222021
FMED+9.7%+2.5%+1.4%−21.7%+11.0%

Source: Fund prospectus bar chart (risk/return summary)

Growth of $10,000 in FMED

$10,000 invested at the start of 2021 would have been worth about $9,900 by the end of 2025, based on the fund's reported calendar-year returns.

YearReturnValue of $10,000
2025+9.7%$9,898
2024+2.5%$9,023
2023+1.4%$8,808
2022−21.7%$8,689
2021+11.0%$11,099

Trailing returns vs benchmark and category

1 yr5 yr10 yrSince inception
FMED+9.7%−0.2%—+3.4%
Large Blend median+13.8%+9.7%+10.9%—

Source: Prospectus as of Sep 30, 2026; category medians computed by MutualFund.com

Recent monthly returns

For the three months ending May 31, 2026, FMED returned −6.29%, +1.04%, +1.64% (oldest to newest), per SEC Form N-PORT.

Past performance does not guarantee future results. Returns assume reinvested distributions and are net of fund expenses, as reported by the fund.